Effects of angiopoietin 4 on lipopolysaccharide-induced injury of human umbilical vein endothelial cells
Ya Li
Abstract
Ya Li
Abstract
AIM: To observe the effects of angiopoietin 4( Ang-4) on lipopolysaccharide( LPS)-induced injury of human umbilical vein endothelial cells( HUVECs). METHODS: The EnVision immunohistochemical method was used to identify the HUVECs. After pre-treated with different doses of Ang-4 for 0. 5 h,HUVECs was exposed to LPS at concentration of 10 mg / L for 24 h. The cell viability was evaluated by MTT assay. The content of tumor necrosis factor-alpha( TNF-α) in the supernatant and the concentrations of intracellular and supernatant von Willebrand factor( vWF) were detected by ELISA. The mRNA levels of Toll-like receptor 4( TLR4),NF-κB p65 and TNF-α were determined by realtime PCR. RESULTS: Factor Ⅷ in the cytoplasm was positive in the HUVECs. Compared with normal group,LPS reduced the cell viability( P 0. 01),and significantly increased the secretion of TNF-α and vWF( P 0. 01). The mRNA expression of TLR4,NF-κB p65 and TNF-α also increased( P 0. 01). Ang-4 at concentration of 100 μg / L enhanced the cell viability( P 0. 01),reduced the content of vWF and TNF-α,and inhibited the LPS-induced increases in the mRNA levels of TLR4,NF-κB p65 and TNF-α( P 0. 01). CONCLUSION: Ang-4 antagonizes LPS-induced damage in HUVECs by inhibiting TLR4-NF-κB p65-TNF-α signaling pathways.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To observe the effects of angiopoietin 4( Ang-4) on lipopolysaccharide( LPS)-induced injury of human umbilical vein endothelial cells( HUVECs). METHODS: The EnVision immunohistochemical method was used to identify the HUVECs. After pre-treated with different doses of Ang-4 for 0. 5 h,HUVECs was exposed to LPS at concentration of 10 mg / L for 24 h. The cell viability was evaluated by MTT assay. The content of tumor necrosis factor-alpha( TNF-α) in the supernatant and the concentrations of intracellular and supernatant von Willebrand factor( vWF) were detected by ELISA. The mRNA levels of Toll-like receptor 4( TLR4),NF-κB p65 and TNF-α were determined by realtime PCR. RESULTS: Factor Ⅷ in the cytoplasm was positive in the HUVECs. Compared with normal group,LPS reduced the cell viability( P 0. 01),and significantly increased the secretion of TNF-α and vWF( P 0. 01). The mRNA expression of TLR4,NF-κB p65 and TNF-α also increased( P 0. 01). Ang-4 at concentration of 100 μg / L enhanced the cell viability( P 0. 01),reduced the content of vWF and TNF-α,and inhibited the LPS-induced increases in the mRNA levels of TLR4,NF-κB p65 and TNF-α( P 0. 01). CONCLUSION: Ang-4 antagonizes LPS-induced damage in HUVECs by inhibiting TLR4-NF-κB p65-TNF-α signaling pathways.
Key concepts: Umbilical vein, TLR4, Tumor necrosis factor alpha, Lipopolysaccharide, Viability assay, Chemistry, Human umbilical vein endothelial cell, Von Willebrand factor